3I was founded in 2013 to develop a cost-effective, accurate, and easy-to-use diagnostic that would improve the effectiveness of antibiotics-related clinical decisions. |
|
3i Diagnostics
3I was founded in 2013 to develop a cost-effective, accurate, and easy-to-use diagnostic that would improve the effectiveness of antibiotics-related clinical decisions. |
|
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.